Dyspepsia Completed Phase 2 Trials for Esomeprazole (DB00736)

Also known as: Indigestion

IndicationStatusPhase
DBCOND0004526 (Dyspepsia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00222131Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD PatientsTreatment
NCT00723502Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected PatientsTreatment
NCT00303264The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.Treatment